Hepatocellular Carcinoma (HCC) – Richard Finn, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019

Hepatocellular Carcinoma (HCC) – Richard Finn, MD, and Robert Figlin, MD, discuss clinical highlights from ASCO GI 2019

Wednesday February 13, 2019

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Richard Finn, MD, Professor of Medicine at the Geffen School of Medicine, UCLA, discuss hepatocellular carcinoma (HCC) clinical highlights from ASCO GI 2019

Featured Videos

Marwan G. Fakih, MD, on why AMG 510 seems promising in colorectal and lung cancers

Paul G. Richardson, MD, considers progression-free survival in MM when treating with isatuximab

Saad Usmani, MD, FACP, considers data in smoldering MM coming out of ASCO 2019